Tuesday 14 June 2022
Nienke van Dongen and Ruben Kolkman were awarded together with the poster prize and business impact prize at the MESA+ meeting 2022. In their work they showed that we can enrich and detect hmDNA, which is known to be a cancer biomarker. Currently we are adapting these methods to measure DNA present in urine of healthy volunteers and patients diagnosed with cancer.
